Skip to content
WSTWest Pharmaceutical Services

WST Earnings

West Pharmaceutical Services next reports earnings on July 23, 2026. Track record: 4/4 beats.

Next Earnings In

07Days
:
03Hours
:
24Min
:
10Sec

Thursday, July 23, 2026

Current Price

$359.00

EPS Estimate

Earnings Per Share

$2.08

+13.1% YoY

Trailing EPS

Last 12 months earnings

$7.50

Beat Rate

4/4

100%

Forward P/E

Price-to-Earnings ratio

37.3

Margin: 16.8%

Analyst Rating

Strong Buy

15 analysts

Analyst Sentiment

Strong Buy15 analysts
Target: $382.00+6.4%Full analysis →

Earnings History

4/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-03-31$1.68$2.13+27.1%Beat
2025-12-31$1.83$2.04+11.5%Beat
2025-09-30$1.71$1.96+14.5%Beat
2025-06-30$1.54$1.84+19.7%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$2.08+13.1%
Next Qtr(+1q)$2.12+8.3%
Current Year(0y)$8.62+18.2%
Next Year(+1y)$9.62+11.7%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$2.08

Revenue Estimate

$840M

Annual EPS Est.

$8.62

+18.2% YoY

WST Earnings FAQ

When is WST's next earnings date?

West Pharmaceutical Services (WST) is expected to report earnings on July 23, 2026. The consensus EPS estimate is $2.08.

Does WST usually beat earnings estimates?

West Pharmaceutical Services has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).

What is WST's trailing EPS?

West Pharmaceutical Services's trailing twelve-month EPS is $7.50. This is calculated from the last four quarters of reported earnings.

What do analysts think about WST?

15 Wall Street analysts cover West Pharmaceutical Services. The consensus rating is "Strong Buy" with an average price target of $382.00, implying 6.4% upside from the current price.